Literature DB >> 29948457

Q-switched double frequency Nd:YAG 532-nm nanosecond laser vs. double frequency Nd:YAG 532-nm picosecond laser for the treatment of solar lentigines in Asians.

Vasanop Vachiramon1, Wimolsiri Iamsumang2, Korn Triyangkulsri2.   

Abstract

Solar lentigines are common pigmentary lesions. Q-switched lasers are effective treatment options but postinflammatory hyperpigmentation (PIH) is common in darker skin. The objective of the study is to compare the efficacy and safety in solar lentigines of Asian skin treated by Q-switched potassium titanyl phosphate (KTP) 532-nm nanosecond laser vs. KTP 532-nm picosecond laser for the treatment of solar lentigines in Asians. Thirty patients with at least 2 solar lentigines on the upper extremities were enrolled. A total of 30 paired lentiginous lesions were randomly treated with a single treatment of either Q-switched KTP 532-nm nanosecond laser vs. KTP 532-nm picosecond laser. In terms of efficacy, mean luminance score was evaluated at baseline, at 6th, and 12th week. Degree of pigment clearance was assessed by a blinded physician and the patients. Satisfaction score was rated by patients using visual analogue scale. Adverse events were also recorded. Twenty-eight patients completed the study. Both lasers showed significant improvement in mean luminance score from baseline (p < 0.05). Likewise, there was no significant difference in pigment clearance between two lasers either assessed by physician or patients. However, patients' satisfaction score was significantly higher with the picosecond laser (p = 0.014). Adverse events and pain were not different between groups. Q-switched KTP 532-nm nanosecond laser and KTP 532-nm picosecond laser are safe and effective for treating solar lentigines in Asians. Based on cost-effectiveness, Q-switched KTP 532-nm nanosecond laser remains the main treatment while KTP 532-nm picosecond laser can be considered as a treatment option.

Entities:  

Keywords:  Age spot; Melasma; Pigmentary disorder; Postinflammatory hyperpigmentation; Potassium titanyl phosphate

Mesh:

Year:  2018        PMID: 29948457     DOI: 10.1007/s10103-018-2560-3

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  15 in total

1.  A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: a randomized, physician-blinded, split-face comparative trial.

Authors:  Chia-Chen Wang; Yuh-Mou Sue; Chih-Hsiung Yang; Chih-Kang Chen
Journal:  J Am Acad Dermatol       Date:  2006-05       Impact factor: 11.527

2.  Comparative study of treatment efficacy and the incidence of post-inflammatory hyperpigmentation with different degrees of irradiation using two different quality-switched lasers for removing solar lentigines on Asian skin.

Authors:  K Negishi; H Akita; S Tanaka; Y Yokoyama; S Wakamatsu; K Matsunaga
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-12-20       Impact factor: 6.166

3.  Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.

Authors:  Melissa Kanchanapoomi Levin; Elise Ng; Yoon-Soo Cindy Bae; Jeremy A Brauer; Roy G Geronemus
Journal:  Lasers Surg Med       Date:  2016-02       Impact factor: 4.025

4.  Comparison of responses of tattoos to picosecond and nanosecond Q-switched neodymium: YAG lasers.

Authors:  V Ross; G Naseef; G Lin; M Kelly; N Michaud; T J Flotte; J Raythen; R R Anderson
Journal:  Arch Dermatol       Date:  1998-02

Review 5.  Benign pigmented lesions.

Authors:  Inja Bogdan Allemann; David J Goldberg
Journal:  Curr Probl Dermatol       Date:  2011-08-16

6.  A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial.

Authors:  M M Todd; T M Rallis; J W Gerwels; T R Hata
Journal:  Arch Dermatol       Date:  2000-07

7.  Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals.

Authors:  K Yoshimura; K Harii; T Aoyama; T Iga
Journal:  Plast Reconstr Surg       Date:  2000-03       Impact factor: 4.730

Review 8.  Pigmentary changes of the ageing skin.

Authors:  J P Ortonne
Journal:  Br J Dermatol       Date:  1990-04       Impact factor: 9.302

9.  Comparison of Q-switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asians.

Authors:  Vasanop Vachiramon; Wikanda Panmanee; Thanya Techapichetvanich; Kumutnart Chanprapaph
Journal:  Lasers Surg Med       Date:  2016-01-12       Impact factor: 4.025

10.  Prospective study of removing solar lentigines in Asians using a novel dual-wavelength and dual-pulse width picosecond laser.

Authors:  Kei Negishi; Hirotaka Akita; Yukiko Matsunaga
Journal:  Lasers Surg Med       Date:  2018-04-02       Impact factor: 4.025

View more
  5 in total

Review 1.  Laser treatment of benign melanocytic lesion: a review.

Authors:  Farnaz Araghi; Laya Ohadi; Hamideh Moravvej; Maliheh Amani; Farzad Allameh; Sahar Dadkhahfar
Journal:  Lasers Med Sci       Date:  2022-09-12       Impact factor: 2.555

2.  Picosecond Laser-Induced Photothermal Skin Damage Evaluation by Computational Clinical Trial.

Authors:  Y Shimojo; T Nishimura; H Hazama; N Ito; K Awazu
Journal:  Laser Ther       Date:  2020-07-17

3.  A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-Containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy.

Authors:  Hye One Kim; Hye Ran Kim; Jin Cheol Kim; Seok Young Kang; Min Je Jung; Sung Eun Chang; Chun Wook Park; Bo Young Chung
Journal:  Medicina (Kaunas)       Date:  2021-02-13       Impact factor: 2.430

4.  Treatment of facial and non-facial lentigines with a 730 nm picosecond titanium: Sapphire laser is safe and effective.

Authors:  Arielle N B Kauvar; Rongrong Sun; Jag Bhawan; Gaurav Singh; Nkem Ugonabo; Hao Feng; Kevin Schomacker
Journal:  Lasers Surg Med       Date:  2021-08-17

Review 5.  Update on Melasma-Part II: Treatment.

Authors:  Daniel P Cassiano; Ana Cláudia C Espósito; Carolina N da Silva; Paula B Lima; Joana A F Dias; Karime Hassun; Luciane D B Miot; Hélio A Miot; Ediléia Bagatin
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.